1/ We studied the quality,
quantity and persistence of #SARSCoV2 antibodies in primary school students (6-11 year-olds) compared to staff (adults) over 6 months (until ~7-8 months after their #SARSCoV2 infection)
2/ The proportion of students & staff who had #SARSCoV2 antibodies in back June 2020 was similar:
👉 11.5% (95%CI, 9.4-13.9) & 11.3% (95%CI, 9.2-13.6; p=0.88) students had nucleoprotein & RBD antibodies vs 15.6% (95%CI, 13.7-17.6) & 15.3% (95%CI, 13.4-17.3; p=0.83) staff
3/ Live virus neutralising activity (ability of antibody to kill #SARSCoV2) was detected in 79.8% (71/89) of N antibody & 85.5% (71/83) of RBD antibody positive kids. RBD correlated more strongly with neutralising activity (rs=0.75; p<0.0001) than N antibodies (rs=0.37; p<0.0001)
4/ After 6 months, 58% (107/184) of participants lost their N antibody vs 21% (33/158) for RBD antibody (p<0.001). There’s something about Abbott N assay that loses positivity over time. Others N assays remain positive with time. That’s why we retested all samples using RBD assay
5/ Importantly though, the proportion of students & staff who lost their #SARSCoV2 antibodies more than 6 months after their infection was small similar between students and staff for both N (p=0.26) and RBD-antibodies (p=0.43) 👉 medrxiv.org/content/10.110…
6/ Interestingly, the amount (titres) of N (p=0.028) & RBD (p<0.0001) antibodies back in June 2020 were significantly higher in students than in staff but ended up at similar levels after 6 months in December 2020 (p=0.16 & p=0.37, respectively)
7/ In conclusion, young children are able to mount strong immune responses against #SARSCoV2 (better than adults) even if most of them have asymptomatic infection. They are also able to retain their immunity for >6 months, at least as well as adults
1/ We developed & validated an oral fluid assay to measure #SARSCoV2 antibodies. Basically it’s a lollipop stick with a sponge that collects oral fluid (saliva) from around cheeks/gums. Kids can do the test themselves & sample can be posted to the lab 🧵👉 medrxiv.org/content/10.110…
2/ Here’s the technical stuff: We used contemporaneous blood & oral fluid samples from ~2,000 kids & adults taking part in our school studies and developed 3 different oral fluid assays for testing & validating: N-antibody, Spike-antibody & RBD-antibody 👉 medrxiv.org/content/10.110…
3/ The N-protein capture assay was the best candidate, sensitivity 75% (95%CI, 71–79%) specificity 99% (95% CI: 78–99%) when compared with paired serum antibodies, but higher sensitivity in kids (80%, 95% CI: 71–88%) than adults (67%, CI: 60%-74%) 👉 medrxiv.org/content/10.110…
1/9. In England, #SARSCoV2 infection rates in school-aged kids & #COVID19 outbreaks have both ⬆️ in recent weeks (latest data 4 July) but that does not change the narrative on kids & their role in infection/transmission in school
2/9. No one has claimed that kids don’t get infected or don’t transmit #SARSCoV2 to others. But the data suggest that lower risk with kids than adults. Eg. We don’t see two-thirds of staff/students infected in a single outbreak as we do in care homes 👉 thelancet.com/journals/eclin…
3/9. We & others have shown that #SARSCoV2 cases & outbreaks reflect community infection rates. Cases in kids generally follow adults *unless* adults are in lockdown & kids continue to go to school. This happened in Nov/Dec 2020 & Mar/Apr 2021. See👇👇
1/4 Childhood #COVID19 deaths. This preprint by @RCPCHtweets & @PHE_uk provides critical new information about #SARSCoV2 and kids which we didn’t have until now. Here’s why the small numbers in this paper matter 🧵
2/4 Death is the most objective outcome & can be accurately measured in countries like England. The results show ~3,000 of 12 million kids died in 1 year & only 61 with #SARSCoV2. Detailed medical record analysis showed only 25 (42%) died *of* #COVID19
3/4. Of the 25 kids who died of #COVID19, 19/25 (76%) had underlying conditions & of these 15/19 (60%) had a life-limiting condition & mostly with 2 or more medical conditions, esp. severe neurological conditions
2/5 Compared to 2 doses of the same vaccine brand, mixing Pfizer/AZ vaccines was associated with higher rates of severe reactions & requiring medical attention after the 2nd dose: esp. in younger adults, in women & in those with previous #COVID19 🧵
3/5 Adults who had a severe reaction after their 1st dose of #COVID19 were more likely to have a severe reaction after 2nd dose, whichever vaccine they received, but risk of severe reactions increased if 2 different vaccine (AZ/Pfizer) brands given 🧵
1/ News outlets & people on social media have been misinterpreting data on exposures prior to diagnosis as places where people caught #SARSCoV2 (provided in the @PHE_uk Weekly Reports)
2/. UK has been in lockdown since Nov. In Mar 2021, only schools reopened ➡️ 9 million children & education staff were out in the community. The figure below shows that a person was attending school prior to testing +ve for #SARSCoV2 - not that they caught #SARSCoV2 in school
3/ But as we eased into step 3 of opening lockdown, people were more likely to have visited other venues prior to testing +ve for #SARSCoV2
Here’s the same graph for the latest week reported. Eating out & “other” are now more frequent because restaurants & shops are open 👇